GlaxoSmithKline Consumer Healthcare records 21% growth
§ Sales up 21% and Profits up 16%
Highlights for the Year
§ High double-digit growth in Sales and Profits for second consecutive year in 2008
§ Recommended a Final Dividend @ 50%, a total of 150 % for the year
§ Focus on existing and new products through innovation
§ Cost curtailment initiatives to control cost of inputs
§ Aggressive Retention and Development programs for key talent
Gurgaon, NCR, Jan 27 2009: GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the year ended December 31, 2008. Net Sales at Rs. 15,42,78 lakhs recorded an impressive growth of 21% over 2007 with PAT at Rs. 1,88,33 lakhs growing by 16% for the same period and PBT growing by 16% over last year to Rs. 2,84,08 lakhs. For the Fourth quarter, net sales were Rs. 3,33,37 lakhs, while PBT and PAT were Rs. 50,72 lakhs and Rs. 32,58 lakhs respectively.
In the Golden Jubilee year of the Company, the Board of Directors recommended a final dividend @ Rs. 5 per equity share of Rs.10 each to share success with its shareholders. This is in addition to the interim dividend of 100% paid during November 2008.
“Despite market sentiments, GSKCH continued its strong performance in 2008 by achieving high double digit sales growth for yet another year. This has been achieved through focus on existing brands and cost control measures” said Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd.
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Leave a comment